Clinical Trial Update: Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Small Cell Lung Cancer, or Mesothelioma [Phase 1]

View source ↗

Summary

Phase 1 trial of a cancer vaccine therapy with GM-CSF in patients with acute myeloid leukemia, myelodysplastic syndromes, non-small cell lung cancer, mesothelio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Malignant Mesothelioma
• Myelodysplastic Syndromes
• Non-small Cell Lung Cancer
• Peritoneal Cancer

Drugs mentioned

• GM-CSF (granulocyte-macrophage colony-stimulating factor)
• cancer vaccine (cancer vaccine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2016-03-02